Canopy Growth CGC shares jumped Monday when the company announced the appointment of Constellation Brands STZ CFO David Klein as the cannabis company's CEO.
The Analyst
Cantor Fitzgerald’s Pablo Zuanic reiterated a Neutral rating on Canopy Growth with a CA$18.90 ($14.27) price target.
Canopy Finally Replaces Linton
Zuanic was surprised it has taken this long for Canopy Growth to hire a new CEO after Bruce Linton's departure, the analyst said in a Monday note. (See his track record here.)
“Pundits trying to read the tea leaves could make arguments both pro and con regarding whether the probability of a bid by STZ has increased or not,” the analyst said.
Those chances have increased, he said, explaining there is a more than a two-thirds probability of Constellation Brands putting in a bid for all Canopy Growth’s equity very soon, he said.
On the other hand, Zuanic said that acquiring Canopy Growth can’t be an easy strategic decision for Constellation Brands given “its own balance sheet, (~4x net debt to EBITDA on FY21 consensus), likely mid- to high-teens EPS dilution from a deal for the 65% of WEED it does not own, and likely near-term hit to its own share price.”
Constellation Brands could advocate for acquisition on the argument of an improving outlook for the cannabis industry, and also if it sees Canopy Growth as a strategic investment and not just a financial one, the analyst said.
The THC/CBD beverages being created jointly by the two companies could push them ahead of the competition, both in Canada and globally, Zuanic said.
“We rate the stock Neutral as we are not entirely convinced the premium is justified (taking last qtr sales) and think consensus may be too optimistic for CY20 in relative terms.”
Price Action
Canopy Growth shares were trading 13.48% higher at $21.17 at the time of publication Monday, while Constellation shares were down 1.53% at $180.84.
Related Links:
Canopy Growth's Cannabis 2.0 Products Will Hit Shelves In Canada Next Month
Canopy Growth Is Prepared For 'Cannabis 2.0' In Canada, Analysts Say
Photo courtesy of Canopy Growth.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!